Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients
Cancer Detection and Prevention · 2007-01 · 31 (5) · 402-407
DOI: 10.1016/j.cdp.2007.10.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Detection and Prevention, 2007-01. Verfasst von Luca Beneduce und 6 weiteren Autor:innen. Beteiligte Einrichtung: XEPTAGEN S.p.A., Via delle Industrie 9, Marghera Venezia, Italy. beneduce@xeptagen.com. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: Several reports indicate that the main biomarkers for liver and colorectal cancer circulating in the blood stream associate with immunoglobulin M (IgM) to form stable complexes that show increased diagnostic relevance compared to circulating free biomarkers. METHODS: To further investigate the association between cancer biomarkers and IgM, we assessed the presence of prostate-specific antigen (PSA) as IgM complexes in sera of patients with prostate cancer (PC) or benign prostatic hyperplasia (BPH) in comparison with PSA measurements. RESULTS: PSA-IgM levels were significantly elevated in 40% (20/50) and 12% (6/51) of PC and BPH patients, respectively, compared to 22% (11/50) and 29% (15/51) of PSA positive patients in the same groups. Detection of cancer markedly increased from 22 to 60% by co-determination of both markers (30/50 patients). Significantly elevated levels of PSA-IgM were found in 13 out of 30 patients affected by PC with a PSA value between 4 and 10 ng/mL and only in 4 out of 34 BPH patients in the same PSA range. CONCLUSIONS: The results are the first evidence of the occurrence of PSA-IgM complexes in patients with prostate cancer. The gain achieved in cancer detection by using the combination of PSA and PSA-IgM suggests that PSA-IgM could be a complementary serological marker of prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- XEPTAGEN S.p.A., Via delle Industrie 9, Marghera Venezia, Italy. beneduce@xeptagen.com
Zitieren
APA
Beneduce, L., Prayer-Galetti, T., Giustinian, A. M., Gallotta, A., Betto, G., Pagano, F., & Fassina, G. (2007). Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients. Cancer Detection and Prevention, 31(5), 402-407. https://doi.org/10.1016/j.cdp.2007.10.005
Vancouver
Beneduce L, Prayer-Galetti T, Giustinian AM, Gallotta A, Betto G, Pagano F, et al. Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients. Cancer Detection and Prevention. 2007;31(5):402-407. doi:10.1016/j.cdp.2007.10.005
BibTeX
@article{Beneduce2007,
author = {Beneduce, Luca and Prayer-Galetti, Tommaso and Giustinian, Andrea Marcello Grimani and Gallotta, Andrea and Betto, Giovanni and Pagano, Francesco and Fassina, Giorgio},
title = {Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients},
journal = {Cancer Detection and Prevention},
year = {2007},
volume = {31},
number = {5},
pages = {402--407},
doi = {10.1016/j.cdp.2007.10.005}
}
EUVIMED